Total Payments
$7,767
2024 Payments
$279.30
Companies
28
Transactions
175
Medicare Patients
4,724
Medicare Billing
$1.9M
Payment Breakdown by Category
Food & Beverage$7,602 (97.9%)
Consulting$149.25 (1.9%)
Education$16.24 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,602 | 172 | 97.9% |
| Consulting Fee | $149.25 | 2 | 1.9% |
| Education | $16.24 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $4,389 | 55 | $0 (2024) |
| GlaxoSmithKline, LLC. | $646.59 | 28 | $0 (2023) |
| Respiratory Technologies, Inc. | $531.95 | 13 | $0 (2017) |
| Philips Electronics North America Corporation | $294.01 | 19 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $236.43 | 6 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $223.97 | 14 | $0 (2021) |
| Baxter Healthcare | $149.25 | 2 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $148.52 | 2 | $0 (2020) |
| Amgen Inc. | $125.00 | 1 | $0 (2023) |
| Gilead Sciences, Inc. | $125.00 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $279.30 | 11 | AstraZeneca Pharmaceuticals LP ($71.98) |
| 2023 | $642.96 | 14 | Boehringer Ingelheim Pharmaceuticals, Inc. ($168.66) |
| 2022 | $634.06 | 16 | Boehringer Ingelheim Pharmaceuticals, Inc. ($371.74) |
| 2021 | $1,051 | 21 | Boehringer Ingelheim Pharmaceuticals, Inc. ($756.63) |
| 2020 | $963.29 | 18 | Boehringer Ingelheim Pharmaceuticals, Inc. ($818.18) |
| 2019 | $1,406 | 24 | Boehringer Ingelheim Pharmaceuticals, Inc. ($958.91) |
| 2018 | $1,690 | 45 | Boehringer Ingelheim Pharmaceuticals, Inc. ($874.78) |
| 2017 | $1,102 | 26 | Respiratory Technologies, Inc. ($531.95) |
All Payment Transactions
175 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.95 | General |
| Category: Immunology | ||||||
| 10/25/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $28.33 | General |
| Category: Medical Device | ||||||
| 10/19/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: Respiratory | ||||||
| 10/11/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: RESPIRATORY | ||||||
| 07/26/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $35.32 | General |
| Category: EPILEPSY | ||||||
| 06/21/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: Respiratory | ||||||
| 05/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: RESPIRATORY | ||||||
| 04/19/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $31.03 | General |
| Category: Respiratory | ||||||
| 03/23/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: ANTIBIOTIC | ||||||
| 07/25/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 07/25/2023 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Inflammation | ||||||
| 06/02/2023 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $33.11 | General |
| Category: Neurology | ||||||
| 04/13/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV | Food and Beverage | In-kind items and services | $34.68 | General |
| 04/08/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: Respiratory | ||||||
| 03/27/2023 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $27.07 | General |
| 03/23/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: RESPIRATORY | ||||||
| 03/17/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Respiratory | ||||||
| 03/16/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: DIABETES | ||||||
| 03/07/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $8.98 | General |
| Category: DIABETES | ||||||
| 02/17/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: IMMUNOLOGY | ||||||
| 02/10/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $27.50 | General |
| Category: RESPIRATORY | ||||||
| 01/28/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $27.89 | General |
| Category: RESPIRATORY | ||||||
| 01/13/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,052 | 5,487 | $1.1M | $579,063 |
| 2022 | 17 | 1,362 | 6,256 | $1.7M | $746,359 |
| 2021 | 24 | 1,214 | 4,029 | $982,465 | $373,900 |
| 2020 | 24 | 1,096 | 3,495 | $667,413 | $241,799 |
Total Patients
4,724
Total Services
19,267
Medicare Billing
$1.9M
Procedure Codes
80
All Medicare Procedures & Services
80 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 122 | 1,221 | $550,561 | $240,181 | 43.6% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 154 | 2,071 | $232,814 | $141,574 | 60.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 237 | 1,506 | $168,838 | $108,809 | 64.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 147 | 174 | $59,090 | $27,534 | 46.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 139 | 174 | $28,904 | $18,902 | 65.4% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 60 | 67 | $17,341 | $11,064 | 63.8% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2023 | 31 | 61 | $16,627 | $8,626 | 51.9% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 46 | 53 | $11,219 | $7,409 | 66.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 24 | 51 | $10,542 | $5,866 | 55.6% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 47 | 55 | $8,052 | $5,333 | 66.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 18 | 21 | $3,493 | $2,209 | 63.2% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 12 | 15 | $1,940 | $813.15 | 41.9% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 15 | 18 | $1,673 | $744.66 | 44.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 153 | 1,908 | $971,225 | $400,998 | 41.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 295 | 1,810 | $268,348 | $121,838 | 45.4% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 172 | 1,580 | $247,443 | $103,296 | 41.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 203 | 253 | $86,656 | $46,923 | 54.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 195 | 246 | $50,834 | $23,838 | 46.9% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 73 | 77 | $23,018 | $11,940 | 51.9% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 80 | 104 | $15,592 | $8,911 | 57.2% |
| 99310 | Follow-up nursing facility visit per day, typically 35 minutes | Facility | 2022 | 38 | 59 | $18,910 | $7,426 | 39.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 27 | 59 | $13,969 | $6,809 | 48.7% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2022 | 11 | 23 | $7,838 | $3,583 | 45.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 25 | 27 | $5,249 | $2,693 | 51.3% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2022 | 14 | 28 | $9,800 | $2,327 | 23.7% |
About Dr. Steven Badin, MD
Dr. Steven Badin, MD is a Internal Medicine healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1932147873.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Badin, MD has received a total of $7,767 in payments from pharmaceutical and medical device companies, with $279.30 received in 2024. These payments were reported across 175 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($7,602).
As a Medicare-enrolled provider, Badin has provided services to 4,724 Medicare beneficiaries, totaling 19,267 services with total Medicare billing of $1.9M. Data is available for 4 years (2020–2023), covering 80 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Pulmonary Disease, Critical Care Medicine
- Location Brooklyn, NY
- Active Since 06/03/2006
- Last Updated 12/20/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1932147873
Products in Payments
- JARDIANCE (Drug) $4,134
- TRELEGY ELLIPTA (Drug) $432.32
- TEZSPIRE (Biological) $301.79
- BREO (Drug) $176.74
- Wellcentive Undiv (Device) $170.55
- Fluid Sys - SIGMA Spectrum Infus (Device) $149.25
- XIFAXAN (Drug) $144.12
- LONHALA MAGNAIR (Drug) $125.00
- Sexually Transmitted Infectious Disease (Device) $125.00
- XOLAIR (Biological) $121.03
- inCourage (Device) $91.04
- TRULANCE (Drug) $79.85
- Pacemakers (Device) $74.56
- OFEV (Drug) $67.45
- Xolair (Biological) $67.39
- DUPIXENT (Biological) $62.26
- SUNOSI (Drug) $60.97
- SMARTVEST (Device) $57.78
- ZERBAXA (Drug) $41.05
- BREZTRI (Drug) $39.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Brooklyn
Bruce Berger, M.d, M.D
Internal Medicine — Payments: $3.0M
Internal Medicine $3.0M
Dr. Jesi Ramone, Md, MD
Internal Medicine — Payments: $701,491
Internal Medicine $701,491
Dr. Ali El Atat, M.d, M.D
Internal Medicine — Payments: $426,309
Internal Medicine $426,309
Manish Parikh, Md, MD
Internal Medicine — Payments: $360,332
Internal Medicine $360,332
Dr. Samuel Uter, Md, MD
Internal Medicine — Payments: $238,375
Internal Medicine $238,375
Dr. Bharath Reddy, Md, MD
Internal Medicine — Payments: $159,733
Internal Medicine $159,733